Myka Labs

Myka Labs is a private, pre-revenue medical device company founded in 2020 and based in San Francisco. It is developing the Glint(TM) catheter platform and AI-driven surgical awareness solutions to address limitations in intraoperative imaging during complex endoscopic and laparoscopic procedures. Led by a seasoned team with deep clinical and engineering expertise, the company targets significant unmet needs in therapeutic endoscopy, particularly for conditions like esophageal atresia and pancreaticobiliary diseases. Myka Labs is in the development and early clinical evaluation stage, with its technology presented at major surgical conferences.

AI-powered surgical awareness platform with sensing and imaging technologies, including the Glint(TM) catheter, designed to enhance visualization of complex anatomy during therapeutic endoscopy and minimally invasive surgery.

Myka Labs competes in the surgical visualization and endoscopy market, which is dominated by large players like Intuitive Surgical (da Vinci), Medtronic, Olympus, and Boston Scientific. Its differentiation lies in a specific focus on AI-enhanced anatomical awareness for complex therapeutic endoscopy, a segment where pure imaging companies (e.g., Canon, Siemens) and larger robotics firms are also innovating.